PolyProx Therapeutics Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Liquidation
PolyProx Therapeutics General Information
Description
Manufacturer and developer of novel drugs designed to provide new therapies for cancer treatment. The company's drugs use a protein that selectively targets tumor cells and triggers natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and removes disease-causing proteins.
Contact Information
Website
www.polyprox.comCorporate Office
- Jonas Webb Building B910
- Babraham Research Campus
- Cambridge CB22 3AT
- England, United Kingdom
Corporate Office
- Jonas Webb Building B910
- Babraham Research Campus
- Cambridge CB22 3AT
- England, United Kingdom
PolyProx Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Bankruptcy: Liquidation | 25-Jan-2022 | Completed | Bankruptcy: Liquidation | |||
| 3. Seed Round | 02-Mar-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Mar-2019 | $4.44M | $4.44M | Completed | Generating Revenue | |
| 1. University Spin-Out | 07-Nov-2018 | Completed | Startup |
PolyProx Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
PolyProx Therapeutics Signals
PolyProx Therapeutics FAQs
-
When was PolyProx Therapeutics founded?
PolyProx Therapeutics was founded in 2018.
-
Where is PolyProx Therapeutics headquartered?
PolyProx Therapeutics is headquartered in Cambridge, United Kingdom.
-
What is the size of PolyProx Therapeutics?
PolyProx Therapeutics has 9 total employees.
-
What industry is PolyProx Therapeutics in?
PolyProx Therapeutics’s primary industry is Drug Discovery.
-
Is PolyProx Therapeutics a private or public company?
PolyProx Therapeutics is a Private company.
-
What is PolyProx Therapeutics’s current revenue?
The current revenue for PolyProx Therapeutics is .
-
How much funding has PolyProx Therapeutics raised over time?
PolyProx Therapeutics has raised $5.74M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process